While targeting cathepsin B has demonstrated notable therapeutic benefits in cancer treatment, it is evident that singularly focusing on cathepsin B does not eliminate or suppress tumour growth, emphasizing the complexity of the underlying mechanisms [12,13]. The gene discussed is CTSB; the disease is neoplasm.